Dengfeng Liu BS, PhD

Dr. Dengfeng Liu graduated from UC Santa Barbara with Ph.D degree on mass spectrometry. After graduation, Dr. Liu has had over 13 years of extensive experience in biotech / pharmaceutical field and had worked for Medimmune, Amgen, Novartis and Gilead Science. Dr. Liu has solid training and considerable experience in analytical method development, method qualification / validation, method transfer, protein structure characterization, critical quality attributes (CQA) analysis, regulatory filing, and CRO/CMO management etc. Currently, Dr. Liu is an Associate Director at Medimmune focusing on ADC, Bispecific antibody, fusion protein, and mRNA analytical development.